These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38227963)
1. Gut Microbiome Diversity and Antimicrobial Resistance After a Single Dose of Oral Azithromycin in Children: A Randomized Placebo-Controlled Trial. Doan T; Liu Z; Sié A; Dah C; Bountogo M; Ouattara M; Coulibaly B; Kiemde D; Zonou G; Nebie E; Brogdon J; Lebas E; Hinterwirth A; Zhong L; Chen C; Zhou Z; Porco T; Arnold BF; Oldenburg CE; Lietman TM Am J Trop Med Hyg; 2024 Feb; 110(2):291-294. PubMed ID: 38227963 [TBL] [Abstract][Full Text] [Related]
2. Gut Resistome After Oral Antibiotics in Preschool Children in Burkina Faso: A Randomized, Controlled Trial. Oldenburg CE; Hinterwirth A; Sié A; Coulibaly B; Ouermi L; Dah C; Tapsoba C; Cummings SL; Zhong L; Chen C; Sarkar S; Bärnighausen T; Lietman TM; Keenan JD; Doan T Clin Infect Dis; 2020 Jan; 70(3):525-527. PubMed ID: 31149703 [TBL] [Abstract][Full Text] [Related]
3. Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution. Doan T; Worden L; Hinterwirth A; Arzika AM; Maliki R; Abdou A; Zhong L; Chen C; Cook C; Lebas E; O'Brien KS; Oldenburg CE; Chow ED; Porco TC; Lipsitch M; Keenan JD; Lietman TM N Engl J Med; 2020 Nov; 383(20):1941-1950. PubMed ID: 33176084 [TBL] [Abstract][Full Text] [Related]
4. Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR). Arzika AM; Abdou A; Maliki R; Beido N; Kadri B; Harouna AN; Galo AN; Alio MK; Lebas E; Oldenburg CE; O'Brien KS; Chen C; Zhong L; Zhou Z; Yan D; Hinterwirth A; Keenan JD; Porco TC; Lietman TM; Doan T; PLoS Med; 2024 May; 21(5):e1004386. PubMed ID: 38709718 [TBL] [Abstract][Full Text] [Related]
5. Indirect effect of oral azithromycin on the gut resistome of untreated children: a randomized controlled trial. Oldenburg CE; Hinterwirth A; Worden L; Sié A; Dah C; Ouermi L; Coulibaly B; Zhong L; Chen C; Ruder K; Lietman TM; Keenan JD; Doan T Int Health; 2021 Feb; 13(2):130-134. PubMed ID: 32556194 [TBL] [Abstract][Full Text] [Related]
6. Gut Microbial Diversity in Antibiotic-Naive Children After Systemic Antibiotic Exposure: A Randomized Controlled Trial. Doan T; Arzika AM; Ray KJ; Cotter SY; Kim J; Maliki R; Zhong L; Zhou Z; Porco TC; Vanderschelden B; Keenan JD; Lietman TM Clin Infect Dis; 2017 May; 64(9):1147-1153. PubMed ID: 28402408 [TBL] [Abstract][Full Text] [Related]
7. Gut Resistome after Antibiotics among Children with Uncomplicated Severe Acute Malnutrition: A Randomized Controlled Trial. Oldenburg CE; Hinterwirth A; Ourohiré M; Dah C; Ouédraogo M; Sié A; Boudo V; Chen C; Ruder K; Zhong L; Lebas E; Nyatigo F; Arnold BF; O'Brien KS; Doan T Am J Trop Med Hyg; 2022 Jul; 107(1):59-64. PubMed ID: 35895362 [TBL] [Abstract][Full Text] [Related]
8. Rapid Reduction of Hinterwirth A; Sié A; Coulibaly B; Ouermi L; Dah C; Tapsoba C; Zhong L; Chen C; Lietman TM; Keenan JD; Doan T; Oldenburg CE Am J Trop Med Hyg; 2020 Sep; 103(3):1266-1269. PubMed ID: 32524948 [No Abstract] [Full Text] [Related]
9. Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution. Doan T; Hinterwirth A; Worden L; Arzika AM; Maliki R; Abdou A; Kane S; Zhong L; Cummings ME; Sakar S; Chen C; Cook C; Lebas E; Chow ED; Nachamkin I; Porco TC; Keenan JD; Lietman TM Nat Med; 2019 Sep; 25(9):1370-1376. PubMed ID: 31406349 [TBL] [Abstract][Full Text] [Related]
10. Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial. Arzika AM; Maliki R; Abdou A; Mankara AK; Harouna AN; Cook C; Hinterwirth A; Worden L; Zhong L; Chen C; Ruder K; Zhou Z; Lebas E; O'Brien KS; Oldenburg CE; Le V; Arnold BF; Porco TC; Keenan JD; Lietman TM; Doan T Clin Infect Dis; 2021 Oct; 73(7):1292-1295. PubMed ID: 34037753 [TBL] [Abstract][Full Text] [Related]
11. Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial. Wei S; Mortensen MS; Stokholm J; Brejnrod AD; Thorsen J; Rasmussen MA; Trivedi U; Bisgaard H; Sørensen SJ EBioMedicine; 2018 Dec; 38():265-272. PubMed ID: 30478001 [TBL] [Abstract][Full Text] [Related]
12. Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR). O'Brien KS; Arzika AM; Amza A; Maliki R; Ousmane S; Kadri B; Nassirou B; Mankara AK; Harouna AN; Colby E; Lebas E; Liu Z; Le V; Nguyen W; Keenan JD; Oldenburg CE; Porco TC; Doan T; Arnold BF; Lietman TM; BMC Public Health; 2021 Apr; 21(1):822. PubMed ID: 33926403 [TBL] [Abstract][Full Text] [Related]
13. Minimal Impact on the Resistome of Children in Botswana After Azithromycin Treatment for Acute Severe Diarrheal Disease. Guitor AK; Katyukhina A; Mokomane M; Lechiile K; Goldfarb DM; Wright GD; McArthur AG; Pernica JM J Infect Dis; 2024 Jul; 230(1):239-249. PubMed ID: 39052715 [TBL] [Abstract][Full Text] [Related]
14. Gut Microbiome among Children with Uncomplicated Severe Acute Malnutrition in a Randomized Controlled Trial of Azithromycin versus Amoxicillin. Oldenburg CE; Hinterwirth A; Dah C; Millogo O; Coulibaly B; Ouedraogo M; Sié A; Chen C; Zhong L; Ruder K; Lebas E; Nyatigo F; Arnold BF; O'Brien KS; Doan T Am J Trop Med Hyg; 2023 Jan; 108(1):206-211. PubMed ID: 36509053 [TBL] [Abstract][Full Text] [Related]
15. Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review. Luchen CC; Chibuye M; Spijker R; Simuyandi M; Chisenga C; Bosomprah S; Chilengi R; Schultsz C; Mende DR; Harris VC PLoS Med; 2023 Jun; 20(6):e1004235. PubMed ID: 37368871 [TBL] [Abstract][Full Text] [Related]
16. Malaria positivity following a single oral dose of azithromycin among children in Burkina Faso: a randomized controlled trial. Brogdon J; Dah C; Sié A; Bountogo M; Coulibaly B; Kouanda I; Ouattara M; Compaoré G; Nebie E; Seynou M; Lebas E; Nyatigo F; Hu H; Arnold BF; Lietman TM; Oldenburg CE BMC Infect Dis; 2022 Mar; 22(1):285. PubMed ID: 35337289 [TBL] [Abstract][Full Text] [Related]
17. Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo. Hare KM; Grimwood K; Chang AB; Chatfield MD; Valery PC; Leach AJ; Smith-Vaughan HC; Morris PS; Byrnes CA; Torzillo PJ; Cheng AC Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2275-85. PubMed ID: 26363637 [TBL] [Abstract][Full Text] [Related]
18. Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger. Hazel A; Arzika AM; Abdou A; Lebas E; Porco TC; Maliki R; Doan T; Lietman TM; Keenan JD; Blumberg S Am J Trop Med Hyg; 2023 Nov; 109(5):1107-1112. PubMed ID: 37783458 [TBL] [Abstract][Full Text] [Related]
19. Effect of amoxicillin on the gut microbiome of children with severe acute malnutrition in Madarounfa, Niger: a retrospective metagenomic analysis of a placebo-controlled trial. Schwartz DJ; Langdon A; Sun X; Langendorf C; Berthé F; Grais RF; Trehan I; Isanaka S; Dantas G Lancet Microbe; 2023 Nov; 4(11):e931-e942. PubMed ID: 37866373 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin. Djamin RS; Talman S; Schrauwen EJA; von Wintersdorff CJH; Wolffs PF; Savelkoul PHM; Uzun S; Kerstens R; van der Eerden MM; Kluytmans JAJW Antimicrob Resist Infect Control; 2020 Jul; 9(1):116. PubMed ID: 32723393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]